Potential of pluripotent stem cells for diabetes therapy

Current Diabetes Reports

Volumn 12, Issue 5, 2012, Pages 490-498

  Schroeder, Insa S ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

3D co culture; Diabetes; Human embryonic stem cells; Induced pluripotent stem cells; Insulin producing cells; Terminal differentiation; Translation

Indexed keywords

INSULIN;

ARTICLE; CELL DIFFERENTIATION; CELL INTERACTION; CELL MATURATION; CELL PROLIFERATION; COCULTURE; COMORBIDITY; EMBRYONIC STEM CELL; GENE FUNCTION; GENETIC PREDISPOSITION; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLURIPOTENT STEM CELL; STEM CELL TRANSPLANTATION;

CELL DIFFERENTIATION; DIABETES MELLITUS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INSULIN-SECRETING CELLS; PLURIPOTENT STEM CELLS;

EID: 84870792582     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-012-0292-5     Document Type: Article

References (99)

1. Grarup N, Overvad M, Sparso T, et al. The diabetogenic VPS13C/C2CD4A/C2CD4B rs7172432 variant impairs glucose-stimulated insulin response in 5722 non-diabetic Danish individuals. Diabetol. 2011;54:789-94.
2. Ingelsson E, Langenberg C, Hivert MF, et al. Detailed physiologic characterization reveals diverse mechanisms for novel genetic loci regulating glucose and insulin metabolism in humans. Diabetes. 2010;59:1266-75.
3. Manolopoulos VG, Ragia G, Tavridou A. Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective. Pharmacogenomics. 2011;12:1161-91.
4. Power C, Rasko JE. Will cell reprogramming resolve the embryonic stem cell controversy? A narrative review. Ann Intern Med. 2011;155:114-21.
5. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nat. 1981;292:154-56. (Pubitemid 11050741)
6. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Sci. 1998;282:1145-47. (Pubitemid 28516247)
7. D'Amour KA, Bang AG, Eliazer S, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol. 2006;24:1392-401. (Pubitemid 44722103)
8. Kroon E, Martinson LA, Kadoya K, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucoseresponsive insulin-secreting cells in vivo. Nat Biotechnol. 2008;26:443-52. (Pubitemid 351501814)
9. Sui J, Mehta M, Shi B, et al. Directed Differentiation of Embryonic Stem Cells Allows Exploration of Novel Transcription Factor Genes for Pancreas Development. Stem Cell Rev. 2012.
10. Jiang J, Au M, Lu K, et al. Generation of insulin-producing isletlike clusters from human embryonic stem cells. Stem Cells. 2007;25:1940-53. (Pubitemid 47258172)
11. Phillips BW, Hentze H, Rust WL, et al. Directed differentiation of human embryonic stem cells into the pancreatic endocrine lineage. Stem Cells Dev. 2007;16:561-78. (Pubitemid 47378729)
12. Segev H, Fishman B, Ziskind A, et al. Differentiation of human embryonic stem cells into insulin-producing clusters. Stem Cells. 2004;22:265-74. (Pubitemid 38736611)
13. Zhang D, Jiang W, Liu M, et al. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin- producing cells. Cell Res. 2009;19:429-38.
14. Nakanishi M, Hamazaki TS, Komazaki S, et al. Pancreatic tissue formation from murine embryonic stem cells in vitro. Differ. 2007;75:1-11. (Pubitemid 46115409)
15. Shi Y, Hou L, Tang F, et al. Inducing embryonic stem cells to differentiate into pancreatic beta cells by a novel 3-step approach with activin A and all-trans retinoic acid. Stem Cells. 2005;23:656-62. (Pubitemid 40647262)
16. Shim JH, Kim SE, Woo DH, et al. Directed differentiation of human embryonic stem cells towards a pancreatic cell fate. Diabetol. 2007;50:1228-38. (Pubitemid 46701546)
17. Cai J, Yu C, Liu Y, et al. Generation of homogeneous PDX1(+) pancreatic progenitors from human ES cell-derived endoderm cells. J Mol Cell Biol. 2010;2:50-60.
18. Rolletschek A, Kania G, Wobus AM. Generation of pancreatic insulin-producing cells from embryonic stem cells -'proof of principle', but questions still unanswered. Diabetol. 2006;49:2541-45.
19. Vaca P, Berna G, Martin F, et al. Nicotinamide induces both proliferation and differentiation of embryonic stem cells into insulin-producing cells. Transplant Proc. 2003;35:2021-23. (Pubitemid 37093799)
20. Chen C, Chai J, Singh L, et al. Characterization of an in vitro differentiation assay for pancreatic-like cell development from murine embryonic stem cells:detailed gene expression analysis. Assay Drug Dev Technol. 2011;9:403-19.
21. Schroeder IS, Rolletschek A, Blyszczuk P, et al. Differentiation of mouse embryonic stem cells to insulin-producing cells. Nat Protoc. 2006;1:495-507.
22. Marenah L, McCluskey JT, Abdel-Wahab YH, et al. A stable analogue of glucose-dependent insulinotropic polypeptide, GIP (LysPAL16), enhances functional differentiation of mouse embryonic stem cells into cells expressing islet-specific genes and hormones. Biol Chem. 2006;387:941-7. (Pubitemid 44100241)
23. Tam PP, Loebel DA. Gene function in mouse embryogenesis:get set for gastrulation. Nat Rev Genet. 2007;8:368-81. (Pubitemid 46625808)
24. Takenaga M, Fukumoto M, Hori Y. Regulated Nodal signaling promotes differentiation of the definitive endoderm and mesoderm from ES cells. J Cell Sci. 2007;120:2078-90. (Pubitemid 47010003)
25. Sulzbacher S, Schroeder IS, Truong TT, et al. Activin A-induced differentiation of embryonic stem cells into endoderm and pancreatic progenitors-the influence of differentiation factors and culture conditions. Stem Cell Rev Rep. 2009;5:159-73.
26. Smith KN, Singh AM, Dalton S. Myc represses primitive endoderm differentiation in pluripotent stem cells. Cell Stem Cell. 2010;7:343-54.
27. Zhou J, Su P, Wang L, et al. mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells. Proc Natl Acad Sci USA. 2009;106:7840-5.
28. Manganelli G, Fico A, Masullo U, et al. Modulation of the pentose phosphate pathway induces endodermal differentiation in embryonic stem cells. PLoS One. 2012;7:e29321.
29. Blyszczuk P, Czyz J, Kania G, et al. Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc Natl Acad Sci U S A. 2003;100:998-1003. (Pubitemid 36183944)
30. Marchand M, Schroeder IS, Markossian S, et al. Mouse ES cells over-expressing the transcription factor NeuroD1 show increased differentiation towards endocrine lineages and insulin-expressing cells. Int J Dev Biol. 2009;53:569-78.
31. Johansson KA, Dursun U, Jordan N, et al. Temporal control of neurogenin3 activity in pancreas progenitors reveals competence windows for the generation of different endocrine cell types. Dev Cel. 2007;12:457-65.
32. Schwitzgebel VM, Scheel DW, Conners JR, et al. Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. Dev. 2000;127:3533-42.
33. Schroeder IS, Sulzbacher S, Nolden T, et al. (2011) Induction and selection of Sox17-expressing endoderm cells generated from murine embryonic stem cells. Cells Tissues Organs.
34. Wang P, Rodriguez RT, Wang J, et al. Targeting SOX17 in human Embryonic stem cells creates unique strategies for isolating and analyzing developing endoderm. Cell Stem Cell. 2011;8:335-46.
35. Gadue P, Gouon-Evans V, Cheng X, et al. Generation of monoclonal antibodies specific for cell surface molecules expressed on early mouse endoderm. Stem Cells. 2009;27:2103-13.
36. Higuchi Y, Shiraki N, Yamane K, et al. Synthesized basement membranes direct the differentiation of mouse embryonic stem cells into pancreatic lineages. J Cell Sci. 2010;123:2733-42.
37. Shiraki N, Yoshida T, Araki K, et al. Guided differentiation of embryonic stem cells into Pdx1-expressing regional-specific definitive endoderm. Stem Cells. 2008;26:874-85.
38. Milewski WM, Temple KA, Wesselschmidt RL, et al. Generation of embryonic stem cells from mouse insulin I promoter-green fluorescent protein transgenic mice and characterization in a teratoma model. In Vitro Cell Dev Biol Anim. 2009;45:1-5.
39. Soria B, Roche E, Berna G, et al. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocininduced diabetic mice. Diabetes. 2000;49:157-62. (Pubitemid 30070992)
40. Tsai ZY, Singh S, Yu SL, et al. Identification of microRNAs regulated by activin A in human embryonic stem cells. J Cell Biochem. 2010;109:93-102.
41. Blum B, Hrvatin SS, Schuetz C, et al. Functional beta-cell maturation is marked by an increased glucose threshold and by expression of urocortin 3. Nat Biotechnol. 2012;30:261-4.
42. Bergstrom R, Strom S, Holm F, et al. Xeno = free culture of human pluripotent stem cells. Methods Mol Biol. 2011;767:125-36.
43. Ilic D, Stephenson E, Wood V, et al. Derivation and feeder-free propagation of human embryonic stem cells under xeno-free conditions. Cytotherapy. 2012;14:122-8.
44. Rajala K, Lindroos B, Hussein SM, et al. A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells. PLoS One. 2010;5:e10246.
45. Lammert E, Cleaver O, Melton D. Induction of pancreatic differentiation by signals from blood vessels. Sci. 2001;294:564-7. (Pubitemid 32999547)
46. Lammert E, Cleaver O, Melton D. Role of endothelial cells in early pancreas and liver development. Mech Dev. 2003;120:59-64. (Pubitemid 35462096)
47. Otonkoski T, Banerjee M, Korsgren O, et al. Unique basement membrane structure of human pancreatic islets: implications for beta-cell growth and differentiation. Diabetes Obes Metab. 2008;10 Suppl 4:119-27.
48. Lee J, Cuddihy MJ, Kotov NA. Three-dimensional cell culture matrices:state of the art. Tissue Eng Part B Rev. 2008;14:61-86.
49. Linke K, Schanz J, Hansmann J, et al. Engineered liver-like tissue on a capillarized matrix for applied research. Tissue Eng. 2007;13:2699-707. (Pubitemid 350076745)
50. Mertsching H, Walles T, Hofmann M, et al. Engineering of a vascularized scaffold for artificial tissue and organ generation. Biomater. 2005;26:6610-17. (Pubitemid 41021753)
51. Mertsching H, Weimer M, Kersen S, et al. Human skin equivalent as an alternative to animal testing. GMS Krankenhhyg Interdiszip. 2008;3:Doc11.
52. Jaramillo M, Banerjee I. Endothelial cell co-culture mediates maturation of human embryonic stem cell to pancreatic insulin producing cells in a directed differentiation approach. J Vis Exp. 2012.
53. Mei Y, Hollister-Lock J, Bogatyrev SR, et al. A high throughput micro-array system of polymer surfaces for the manipulation of primary pancreatic islet cells. Biomater. 2010;31:8989-95.
54. Cui X, Boland T. Human microvasculature fabrication using thermal inkjet printing technology. Biomaterials. 2009;30:6221-27.
55. Cui X, Boland T, D'Lima DD, et al. Thermal inkjet printing in tissue engineering and regenerative medicine. Recent Pat Drug Deliv Formul. 2012.
56. Daoud JT, Petropavlovskaia MS, Patapas JM, et al. Long-term in vitro human pancreatic islet culture using three-dimensional microfabricated scaffolds. Biomater. 2011;32:1536-42.
57. Banerjee M, Virtanen I, Palgi J, et al. Proliferation and plasticity of human beta cells on physiologically occurring laminin isoforms. Mol Cell Endocrinol. 2012;355:78-86.
58. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663-76. (Pubitemid 44233629)
59. Aasen T, Izpisua Belmonte JC. Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells. Nat Protoc. 2010;5:371-82.
60. Aoi T, Yae K, Nakagawa M, et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Sci. 2008;321:699-702.
61. Utikal J, Maherali N, Kulalert W, et al. Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J Cell Sci. 2009;122:3502-10.
62. Kim JB, Zaehres H, Wu G, et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with 2 factors. Nat. 2008;454:646-50.
63. Sun N, Panetta NJ, Gupta DM, et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci U S A. 2009;106:15720-5.
64. Meng X, Neises A, Su RJ, et al. Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone. Mol Ther. 2012;20:408-16.
65. Hanna J, Markoulaki S, Schorderet P, et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell. 2008;133:250-64. (Pubitemid 351508307)
66. Seki T, Yuasa S, Fukuda K. Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus. Nat Protoc. 2012;7:718-28.
67. Stadtfeld M, Brennand K, Hochedlinger K. Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr Biol. 2008;18:890-4.
68. Kim K, Doi A, Wen B, et al. Epigenetic memory in induced pluripotent stem cells. Nat. 2010;467:285-90.
69. Sullivan GJ, Bai Y, Fletcher J, et al. Induced pluripotent stem cells: epigenetic memories and practical implications. Mol Hum Reprod. 2010;16:880-5.
70. Bar-Nur O, Russ HA, Efrat S, et al. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell. 2011;9:17-23.
71. Kim JB, Sebastiano V, Wu G, et al. Oct4-induced pluripotency in adult neural stem cells. Cell. 2009;136:411-19.
72. Sterneckert J, Hoing S, Scholer HR. Concise review: Oct4 and more: the reprogramming expressway. Stem Cells. 2012;30:15-21.
73. Lohle M, Hermann A, Glass H, et al. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors. Stem Cells. 2012;30:570-9.
74. Okita K, Nakagawa M, Hyenjong H, et al. Generation of mouse induced pluripotent stem cells without viral vectors. Sci. 2008;322:949-53.
75. Si-Tayeb K, Noto FK, Sepac A, et al. Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors. BMC Dev Bio. 2010;10:81.
76. Redmer T, Diecke S, Grigoryan T, et al. E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming. EMBO Rep. 2011;12:720-6.
77. Li W, Ding S. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends Pharmacol Sci. 2010;31:36-45.
78. Okita K, Ichisaka T, Yamanaka S. Generation of germlinecompetent induced pluripotent stem cells. Nat. 2007;448:313-17. (Pubitemid 47080336)
79. Fusaki N, Ban H, Nishiyama A, et al. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci. 2009;85:348-62.
80. Kim D, Kim CH, Moon JI, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell. 2009;4:472-6.
81. Zhou H, Wu S, Joo JY, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell. 2009;4:381-4.
82. Thier M, Munst B, Edenhofer F. Exploring refined conditions for reprogramming cells by recombinant Oct4 protein. Int J Dev Biol. 2010;54:1713-21.
83. Warren L, Manos PD, Ahfeldt T, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 2010;7:618-30.
84. Miyoshi N, Ishii H, Nagano H, et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell. 2011;8:633-8.
85. Zhou Q, Melton DA. Extreme makeover: converting one cell into another. Cell Stem Cell. 2008;3:382-8.
86. Zhou Q, Brown J, Kanarek A, et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nat. 2008;455:627-32.
87. Alipio Z, Liao W, Roemer EJ, et al. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells. Proc Natl Acad Sci U S A. 2010;107:13426-31.
88. Jeon K, Lim H, Kim JH, et al. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model. Stem Cells Dev. 2012.
89. Zhu FF, Zhang PB, Zhang DH, et al. Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells. Diabetol. 2011;54:2325-36.
90. Kunisada Y, Tsubooka-Yamazoe N, Shoji M, et al. Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells. Stem Cell Res. 2012;8:274-84.
91. Ohmine S, Squillace KA, Hartjes KA, et al. Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency. Aging. 2012;4:60-73. Albany, NY.
92. Thatava T, Nelson TJ, Edukulla R, et al. Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucoseresponsive insulin-secreting progeny. Gene Ther. 2011;18:283-93.
93. Tateishi K, He J, Taranova O, et al. Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J Biol Chem. 2008;283:31601-7.
94. McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med. 2010;363:2339-50.
95. Maehr R, Chen S, Snitow M, et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A. 2009;106:15768-73.
96. Zhao T, Zhang ZN, Rong Z, et al. Immunogenicity of induced pluripotent stem cells. Nature. 2011;474:212-15.
97. Blanchette JO, Langer SJ, Sahai S, et al. Use of integrin-linked kinase to extend function of encapsulated pancreatic tissue. Biomed Mater. 2010;5:061001.
98. Sakata N, Sumi S, Yoshimatsu G, et al. Encapsulated islets transplantation: past, present and future. World J Gastrointest Pathophysiol. 2012;3:19-26.
99. Kahan B, Magliocca J, Merriam F, et al. Elimination of tumorigenic stem cells from differentiated progeny and selection of definitive endoderm reveals a Pdx1+ foregut endoderm stem cell lineage. Stem Cell Res. 2011;6:143-57.